- High gross margin of 89.4%
- Low bankruptcy risk (Altman Z-Score: 9.70)
- Highly efficient cash conversion (101% FCF/OCF ratio)
Green day on Friday for Rhythm Pharmaceuticals Inc
(Updated on Jul 17, 2026)
The Rhythm Pharmaceuticals Inc stock price gained 0.481% on the last trading day (Friday, 17th Jul 2026), rising from $106.09 to $106.60. During the last trading day the stock fluctuated 4.02% from a day low at $104.21 to a day high of $108.40. The price has fallen in 6 of the last 10 days and is down by -6.63% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 158 thousand more shares were traded than the day before. In total, 761 thousand shares were bought and sold for approximately $81.08 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 31.81% during the next 3 months and, with a 90% probability hold a price between $128.39 and $155.91 at the end of this 3-month period.
RYTM Signals & Forecast
The Rhythm Pharmaceuticals Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $109.10. On a fall, the stock will find some support from the long-term average at approximately $100.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -7.69%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Rhythm Pharmaceuticals Inc stock
On the downside, the stock finds support just below today's level from accumulated volume at $95.83 and $92.31. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rhythm Pharmaceuticals Inc finds support just below today's level at $95.83. If this is broken, then the next support from accumulated volume will be at $92.31 and $89.70.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.19 between high and low, or 4.02%. For the last week, the stock has had daily average volatility of 3.80%.
Our recommended stop-loss: $100.08 (-6.12%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)
Trading Expectations (RYTM) For The Upcoming Trading Day Of Monday 20th
For the upcoming trading day on Monday, 20th we expect Rhythm Pharmaceuticals Inc to open at $106.40, and during the day (based on 14 day Average True Range), to move between $104.39 and $108.81, which gives a possible trading interval of +/-$4.42 (+/-4.23%) up or down from last closing price. If Rhythm Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $107.55 (0.89%) than the support at $95.83 (10.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Rhythm Pharmaceuticals Inc stock A Buy?
Rhythm Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.845
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 20, 2026 - $106.40 ( 0.184%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
RYTM Performance
Trading levels for RYTM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 110.59 | 3.75% |
| R2 | 108.99 | 2.24% |
| R1 | 108.00 | 1.32% |
| Price | 106.60 | |
| S1 | 104.80 | -1.69% |
| S2 | 103.81 | -2.61% |
| S3 | 102.21 | -4.12% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 114.46 | 7.37% |
| R2 | 109.84 | 3.04% |
| R1 | 107.55 | 0.89% |
| Price | 106.60 | |
| S1 | 95.83 | -10.10% |
| S2 | 92.31 | -13.41% |
| S3 | 89.70 | -15.85% |
FAQ
Click here for our free guide on how to buy Rhythm Pharmaceuticals Inc Stock.
Buy RYTM